kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant human c-MET / HGFR Protein, His Tag, 200µg  

Recombinant human c-MET / HGFR Protein, His Tag, 200µg

Recombinant Human HGFR / c-MET Protein (rhHGFR) Glu 25 - Thr 932 produced in human 293 cells (HEK293), His Tag

recombinant human protein, MET, AUTS9, HGFR, RCCP2, c-Met

More details


Availability: within 7 days

494,00 €

Hepatocyte growth factor receptor (HGFR), also known as mesenchymal-epithelial transition factor (MET), c-Met, is a glycosylated receptor tyrosine kinase that plays a central role in epithelial morphogenesis and cancer development. HGFR protein possesses tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. HGFR is normally expressed by cells of epithelial origin, while expression of HGF is restricted to cells of mesenchymal origin. Upon HGF stimulation, HGFR induces several biological responses that collectively give rise to a program known as invasive growth. Abnormal HGFR activation in cancer correlates with poor prognosis, where aberrantly active HGFR triggers tumor growth, formation of new blood vessels (angiogenesis) that supply the tumor with nutrients, and cancer spread to other organs (metastasis). HGFR is deregulated in many types of human malignancies, including cancers of kidney, liver, stomach, breast, and brain. Normally, only stem cells and progenitor cells express HGFR, However, cancer stem cells are thought to hijack the ability of normal stem cells to express HGFR, and thus become the cause of cancer persistence and spread to other sites in the body. Various mutations in the HGFR gene are associated with papillary renal carcinoma. HGFR mediates a complex program known as invasive growth. Activation of HGFR triggers mitogenesis, and morphogenesis [1-4].

Recombinant Human HGF R, His Tag (MET-H5227) is expressed from human 293 cells (HEK293). It contains AA Glu 25 - Thr 932 (Accession # AAI30421.1).
Predicted N-terminus: Glu 25

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The mature form of HGFR is a disulfide-linked heterodimer composed of proteolytically cleaved α and β chain. Each α and β chain has a calculated MW of 32.5 kDa and 70.2 kDa. The protein migrates as 40-45 kDa and 85-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Less than 1.0 EU per μg by the LAL method.

>90% as determined by SDS-PAGE.

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

See Certificate of Analysis for details of reconstitution instruction and specific concentration.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Please refer to product data sheet.

Clinical and Translational Updates

(1) "Evaluation and Characterization of Post-Stroke Lung Damage in a Murine Model of Cerebral Ischemia"
Faura, Ramiro, Simats et al
Int J Mol Sci (2022) 23 (15)
(2) "The Regenerative Effects of c-Met Agonistic Antibodies in Vocal Fold Atrophy"
Choi, Yu, Choi et al
Int J Mol Sci (2022) 23 (14)
(3) "Identifying the focuses of hereditary gingival fibromatosis with bioinformatics strategies"
Zheng, Chen, Deng
Am J Transl Res (2022) 14 (6), 3741-3749
Showing 1-3 of 715 papers.